BioNTech gibt Dosierung des ersten Patienten mit fortgeschrittenem Melanom in der Phase-2-Studie mit mRNA-basiertem BNT111 bekannt
June 18, 2021 05:00 ET
|
BioNTech SE
Erstes Programm aus BioNTechs unternehmenseigener mRNA-Krebsimpfstoff-Plattform FixVac schreitet voran, sodass Patienten erstmals in einer randomisierten klinischen Phase-2-Studie behandelt...
BioNTech Announces First Patient Dosed in Phase 2 Clinical Trial of mRNA-based BNT111 in Patients with Advanced Melanoma
June 18, 2021 05:00 ET
|
BioNTech SE
First program from BioNTech’s fully-owned mRNA cancer vaccine platform FixVac treats patients in a randomized clinical Phase 2 clinical trial Phase 2 trial is based on positive results from Phase 1...
Beroni Group Signs MoU with tella, Inc to Collaborate in Immunotherapy for Cancer Treatment
May 28, 2021 08:30 ET
|
Beroni Group Limited
NEW YORK and SYDNEY, Australia, May 28, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise today...
Global Peptide Cancer Vaccine Clinical Trials Research Market Outlook 2026
April 22, 2021 10:37 ET
|
KuicK Research
DELHI, India, April 22, 2021 (GLOBE NEWSWIRE) -- “Global Peptide Cancer Vaccine Market & Clinical Trials Insight 2026” Report Highlights: Global Peptide Cancer Vaccine Market Trends...
Treos Bio Forms New Subsidiary to Develop a Preventive COVID-19 Peptide Vaccine
June 15, 2020 07:15 ET
|
Treos Bio Corp.
LONDON, June 15, 2020 (GLOBE NEWSWIRE) -- Treos Bio Limited, a clinical stage biopharma company developing targeted peptide cancer immunotherapies, today said that it has developed and successfully...
Treos Bio Reports Positive Final Results of Phase I/II Off-The-Shelf CRC Cancer Immunotherapy in 2020 ASCO Poster Presentation
May 29, 2020 12:17 ET
|
Treos Bio Corp.
LONDON, May 29, 2020 (GLOBE NEWSWIRE) -- Treos Bio Limited, a clinical stage biopharma company developing precision peptide cancer immunotherapies, today presented positive final data from a Phase...
Aldevron Plasmids Used to Support Calviri’s Clinical Trial of a Vaccine Against Canine Cancer
December 03, 2019 09:51 ET
|
Aldevron
TEMPE, A.Z. and FARGO, N.D., Dec. 03, 2019 (GLOBE NEWSWIRE) -- Prevention of cancer onset is the ultimate aspiration for animals and humans. Cancer is caused by mutations that are specific to the...
Treos Bio Announces Positive Interim Results from a Phase 1/2 Clinical Trial of Precision Cancer Vaccine Plus Maintenance Therapy in Patients with Metastatic Colorectal Cancer
May 28, 2019 08:15 ET
|
Treos Bio Corp.
LONDON, May 28, 2019 (GLOBE NEWSWIRE) -- Treos Bio Limited, an immuno-oncology company developing next-generation, precision cancer vaccines combined with companion diagnostic devices, reported...
Innovest Global Provides August Shareholder Update with Milestones Including Patent Approval, Biotech Progress, Financial Achievements
August 13, 2018 07:55 ET
|
Innovest Global, Inc
CLEVELAND, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Innovest Global Inc. (OTC Markets: IVST) (the “Company” or “Innovest”), a Conglomerate with operations in commercial and industrial products and...
GeoVax and Emory University to Collaborate on HPV Therapeutic Program for Head and Neck Cancers
July 30, 2018 09:00 ET
|
GeoVax, Inc.
GeoVax Continues Expansion of its MVA-VLP Vaccine Pipeline with Multiple Collaborations in Infectious Disease and Immuno-oncology ATLANTA, GA, July 30, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc....